Why is Quest Laboratories Ltd falling/rising?

Short-Term Price Momentum and Market Outperformance

Quest Laboratories Ltd’s stock has demonstrated impressive momentum over the past month, surging by 20.56%, a stark contrast to the Sensex’s decline of 1.01% during the same period. This robust monthly gain indicates renewed investor interest and confidence in the company’s prospects. Even over the past week, the stock outperformed the benchmark, rising 3.26% while the Sensex fell by 0.91%. Such relative strength highlights the stock’s appeal amid broader market volatility.

Today’s trading session further reinforced this trend, with Quest Laboratories outperforming its sector by 4.76%. The stock is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a strong technical uptrend. This technical positioning often attracts momentum-driven investors and traders, contributing to the price appreciation.

Fundamental Strengths Supporting the Rally

Despite the stock’s year-to-date decline of 13.55% and a one-year return of -5.64%, Quest Laboratories exhibits strong underlying fundamentals that justify the recent price rise. The company boasts a high Return on Capital Employed (ROCE) of 34.54%, reflecting efficient management and effective utilisation of capital to generate profits. This level of management efficiency is a key factor that investors consider when assessing long-term value.

Additionally, Quest Laboratories maintains a conservative capital structure, with an average Debt to Equity ratio of just 0.09 times. This low leverage reduces financial risk and provides the company with flexibility to invest in growth opportunities without excessive debt burden. The company’s operating profit has grown at an impressive annual rate of 36.74%, signalling healthy long-term growth prospects that support investor confidence.

Moreover, the company’s Return on Equity (ROE) stands at 15.1%, combined with a Price to Book Value of 1.9, indicating a very attractive valuation relative to its earnings and book value. Notably, while the stock price has lagged over the past year, the company’s profits have risen by 34%, suggesting that the market may be beginning to recognise this earnings growth, contributing to the recent price appreciation.

Market Liquidity and Investor Participation

It is worth noting that despite the price rise, investor participation has shown signs of moderation. The delivery volume on 29 Dec was 16.8 thousand shares, representing a significant decline of 60.89% compared to the five-day average delivery volume. This drop in investor participation could indicate that the recent price gains are driven more by existing holders or selective buying rather than broad-based accumulation.

Nevertheless, the stock remains sufficiently liquid for trading, with a trade size capacity based on 2% of the five-day average traded value, ensuring that investors can enter or exit positions without undue market impact.

Balancing Recent Gains with Longer-Term Performance

While the recent price rise is encouraging, it is important to contextualise it within the stock’s longer-term performance. Over the past year, Quest Laboratories has underperformed the Sensex, which has delivered a 9.70% return, whereas the stock declined by 5.64%. The year-to-date performance is even more pronounced, with the stock down 13.55% compared to the Sensex’s 9.70% gain. This divergence suggests that the stock is in a recovery phase, potentially correcting from prior undervaluation or market neglect.

Investors should weigh the company’s strong profit growth and efficient capital management against the recent subdued price performance. The current rally may represent a re-rating as the market begins to factor in the company’s improving fundamentals and growth trajectory.

In summary, Quest Laboratories Ltd’s share price rise on 30-Dec is primarily driven by its strong monthly gains, technical strength above key moving averages, and robust fundamental indicators such as high ROCE, low debt, and significant profit growth. Although investor participation has tapered recently, the stock’s liquidity remains adequate, supporting continued trading activity. The recent outperformance relative to the benchmark and sector highlights renewed investor interest, positioning Quest Laboratories as a stock to watch in the near term.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →